It’s Actually Happening: FDA Moves Toward Allowing Compounding Pharmacies to Produce Banned Peptides

Updated in Real Time

Longevity Peptides Are the Fastest Growing Research Category of 2026. Here’s What’s Driving It

The latest regulatory developments, peer-reviewed research, and industry shifts — curated by the Biostrata Research team for researchers, clinicians, and professionals.

74+

Library Articles

Daily

News Updates

5

Categories

Biostrata Research Weekly

Don't Miss a Development.

The peptide regulatory landscape is shifting fast. Get our weekly industry briefing and stay ahead of every FDA update, new study, and market shift — delivered every Friday morning.

Free. No spam. Research and informational context only.

Research Use Only Notice

By accessing this website, you certify that you are at least 18 years of age and agree to the following terms:

All products sold on this website are intended strictly for laboratory research purposes only and are not for human consumption. These products are not intended to diagnose, treat, cure, or prevent any disease.

The products offered on this website have not been evaluated by the Food and Drug Administration (FDA). The purchaser acknowledges that these products are intended solely for research purposes and assumes full responsibility for their proper handling and use.

By entering this site, you acknowledge that you understand these products are for research use only and agree to comply with all applicable laws and regulations regarding their purchase and use.